{
  "id": 11071295,
  "title": "New investigational drug delivers up to 23.3% weight loss in people with obesity and diabetes",
  "url": "https://urgent.news/2026/10/01/new-investigational-drug-delivers-up-to-23-3-weight-loss-in-people",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-01T00:40:01.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-09-drug-weight-loss-people-obesity.html"
  },
  "original_language": "en",
  "account": "New study data presented at the 2026 EASD annual meeting reveals that a combination of Eli Lilly's experimental drugs eloralintide and tirzepatide (TZP) can lead to significant weight loss and improved blood sugar control in patients with obesity and type 2 diabetes. The 48-week trial involving 367 adults found that the highest dose (Elora 9 mg + TZP 15 mg) resulted in an average 23.3% body weight reduction (24.6 kg or 54.2 pounds) and a 2.9% decrease in HbA1c levels. The most frequent side effects were mild gastrointestinal issues that occurred more often during combination therapy than with either drug alone.",
  "summary": "New data from a phase 2b study being presented at the 2026 annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept. 28–Oct. 2), show that, for people living with obesity and type 2 diabetes, treatment with Eli Lilly's new investigational medication, EloraTZP, a combination of eloralintide and tirzepatide (TZP), resulted in weight loss of up to 23.3% at…",
  "key_points": [
    "Eli Lilly's eloralintide and tirzepatide combination tested",
    "48-week trial with 367 adults showed results",
    "23.3% average weight loss and 2.9% HbA1c decrease"
  ],
  "editors_take": "This development suggests that combining Eli Lilly's experimental drugs could offer a new treatment option for patients with obesity and type 2 diabetes, potentially improving their weight and blood sugar management.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}